[Overview of the use of antihypertensive agents by adults covered by the Québec public prescription drug insurance plan]

L'Institut national d'excellence en sante et en services sociaux (INESSS)
Record ID 32012000848
French
Authors' objectives: The objectives of this study were to provide an overview of the use of antihypertensive drugs from 2007 to 2009 among the beneficiaries of the public prescription drug insurance plan (Régime public d'assurance médicaments, RPAM) aged 18 years or older, and also to compare the use of antihypertensive drugs against optimal use criteria in order to measure compliance with them.
Authors' recommendations: The classes of antihypertensive agents most commonly used in monotherapy during the three study years were ACEIs and especially ARBs. The same two classes were also the most commonly used in combination, especially with diuretics, administered more easily as various fixed-dose formulations. Even if the compliance rates with CHEP criteria were generally high, it would be interesting to conduct a further study to assess a greater interdisciplinary approach would help improve treatment persistence and compliance with CHEP recommendations among new users. The increased use of diuretics and ACEIs, both in monotherapy and in combination therapy, along with the decreased use of ARBs, could serve as quality indicators for first-line use of these drugs in a future study. In addition, hypertension complicated with diabetes or chronic kidney disease could be considered.
Details
Project Status: Completed
Year Published: 2012
English language abstract: An English language summary is available
Publication Type: Not Assigned
Country: Canada
MeSH Terms
  • Antihypertensive Agents
  • Adult
  • Drug Prescriptions
  • Insurance, Health
  • Quebec
Contact
Organisation Name: Institut national d'excellence en sante et en services sociaux
Contact Address: L'Institut national d'excellence en sante et en services sociaux (INESSS) , 2021, avenue Union, bureau 10.083, Montreal, Quebec, Canada, H3A 2S9;Tel: 1+514-873-2563, Fax: 1+514-873-1369
Contact Name: demande@inesss.qc.ca
Contact Email: demande@inesss.qc.ca
Copyright: L'Institut national d'excellence en sante et en services sociaux (INESSS)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.